Cargando…
Maternal body fluid lncRNAs serve as biomarkers to diagnose ventricular septal defect: from amniotic fluid to plasma
Background: Maternal body fluids contain abundant cell-free fetal RNAs which have the potential to serve as indicators of fetal development and pathophysiological conditions. In this context, this study aimed to explore the potential diagnostic value of maternal circulating long non-coding RNAs (lnc...
Autores principales: | Wang, Huaming, Lin, Xi, Wang, Xinda, Liu, Xinxiu, He, Shaozheng, Lyu, Guorong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10516564/ https://www.ncbi.nlm.nih.gov/pubmed/37745849 http://dx.doi.org/10.3389/fgene.2023.1254829 |
Ejemplares similares
-
Differential lncRNA/mRNA expression profiling and ceRNA network analyses in amniotic fluid from foetuses with ventricular septal defects
por: Wang, Huaming, et al.
Publicado: (2023) -
The dimethadione-exposed rat fetus: an animal model for the prenatal ultrasound characterization of ventricular septal defect
por: Yang, Yiru, et al.
Publicado: (2023) -
Circulating microRNA: Myocardium-derived prenatal biomarker of ventricular septal defects
por: Yang, Yiru, et al.
Publicado: (2022) -
Amniotic fluid embolism
por: Rudra, A., et al.
Publicado: (2009) -
Amniotic fluid embolism
por: Thongrong, Cattleya, et al.
Publicado: (2013)